Allogeneic Mesenchymal Precursor Cells Treatment for Chronic Low Back Pain Associated with Degenerative Disc Disease: A Prospective Randomized, Placebo-Controlled 36-Month Study of Safety and Efficacy

Evaluate the safety and efficacy of a single injection of STRO-3+ adult allogeneic mesenchymal precursor cells (MPCs) combined with hyaluronic acid (HA) in subjects with chronic low back pain (CLBP) associated with degenerative disc disease (DDD) through 36 months follow-up.

Source: The Spine Journal - October 8, 2020 Category: Orthopaedics Authors: Kasra Amirdelfan, Hyun Bae, Tory McJunkin, Michael DePalma, Kee Kim, William J. Beckworth, Gary Ghiselli, J. Scott Bainbridge, Randall Dryer, Timothy R. Deer, Roger D. Brown Tags: Clinical Study Source Type: research